Dec 17, 2014 8:00 am EST VolitionRx to Initiate Study with University Hospital Bonn to Confirm NuQ® Test Accuracy in Lung Cancer
Nov 24, 2014 8:00 am EST VolitionRx to Present Positive Data from Pilot Lung Cancer Study at BioWin Day 2014
Nov 11, 2014 8:00 am EST VolitionRx Enters Agreement with University of Oxford to Initiate Endometriosis Study
Oct 31, 2014 8:00 am EDT VolitionRx Initiates Sponsorship of Two-time Cancer Survivor to Drive Awareness for the Importance of Early Cancer Detection
Oct 9, 2014 8:00 am EDT VolitionRx Presents Further Colorectal Cancer Data at 9th International Conference of Anticancer Research
Oct 2, 2014 8:00 am EDT VolitionRx Announces Prostate Cancer Collaboration with the University of Texas MD Anderson Cancer Center
Sep 11, 2014 8:00 am EDT VolitionRx NuQ(R) Blood Test Detects 84% of Colorectal Cancers; Including Both Early- and Later-stage Cancers
Sep 5, 2014 6:30 am EDT VolitionRx to Present at the Aegis Capital Corp. 2014 Healthcare & Technology Conference
Aug 13, 2014 6:30 am EDT VolitionRx Invests in Laboratory Automation System to Increase Throughput Capacity for Large Clinical Trials
